Emergence and Spread of Drug Resistant Neisseria gonorrhoeae

References

• 1 : Emerging antimicrobial resistance in Neisseria gonorrhoeae: urgent need to strengthen prevention strategies. Ann Intern Med2008; 148: 606. Google Scholar
• 2 1993 Sexually transmitted diseases treatment guidelines: Centers for Disease Control and Prevention. MMWR Recomm Rep1993; 42: 1. Google Scholar
• 3 : Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. MMWR Morb Mortal Wkly Rep2007; 56: 332. Google Scholar
• 4 : The use of cephalosporins for gonorrhea: the impending problem of resistance. Expert Opin Pharmacother2009; 10: 555. Google Scholar
• 5 : Emergence and spread of azithromycin-resistant Neisseria gonorrhoeae in Scotland. J Antimicrob Chemother2008; 62: 490. Google Scholar
• 6 : Emergence of high-level azithromycin resistance in Neisseria gonorrhoeae in England and Wales. J Antimicrob Chemother2009; 64: 353. Google Scholar
• 7 : Azithromycin-resistant Neisseria gonorrhoeae strains recently isolated in Italy. J Antimicrob Chemother2009; 63: 1200. Google Scholar
• 8 Performance standards for antimicrobial susceptibility testing; Seventeenth Informational Supplement: Approved standard M100-S17. Wayne, Pennsylvania: Clinical and Laboratory Standards Institute2007. Google Scholar
• 9 : Sexually Transmitted Disease Surveillance 2007 Supplements: Gonococcal Isolate Surveillance Project (GISP) Annual Report 2007. Atlanta, Georgia: U.S. Department of Health and Human Services2009. Google Scholar
• 10 : Evaluation of new anti-infective drugs for the treatment of uncomplicated gonorrhea in adults and adolescents: Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis1992; 15: S123. Google Scholar
• 11 : Drugs of choice for the treatment of uncomplicated gonococcal infections. Clin Infect Dis1995; 20: S47. Google Scholar
• 12 : Update on the management of gonorrhea in adults in the United States. Clin Infect Dis2007; 44: S84. Google Scholar
• 13 : Resistance of Neisseria gonorrhoeae to enoxacin. J Antimicrob Chemother1986; 18: 429. Google Scholar
• 14 : Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 1998: The WHO Western Pacific Gonococcal Antimicrobial Surveillance Programme. Commun Dis Intell2000; 24: 1. Google Scholar
• 15 : Quinolone-resistant Neisseria gonorrhoeae. J Infect Chemother1997; 3: 73. Google Scholar
• 16 : Remarkable increase in central Japan in 2001–2002 of Neisseria gonorrhoeae isolates with decreased susceptibility to penicillin, tetracycline, oral cephalosporins, and fluoroquinolones. Antimicrob Agents Chemother2004; 48: 3185. Google Scholar
• 17 : Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 2006. Commun Dis Intell2008; 32: 48. Google Scholar
• 18 : Annual report of the Australian Gonococcal Surveillance Programme, 2007. Commun Dis Intell2008; 32: 227. Google Scholar
• 19 : European Surveillance of Sexually Transmitted Infections (ESSTI): the first combined antimicrobial susceptibility data for Neisseria gonorrhoeae in Western Europe. J Antimicrob Chemother2006; 58: 587. Google Scholar
• 20 : 2009 European (IUSTI/WHO) guideline on the diagnosis and treatment of gonorrhoea in adults. Int J STD AIDS2009; 20: 453. Google Scholar
• 21 : In vitro selection of fluoroquinolone-resistant Neisseria gonorrhoeae harboring alterations in DNA gyrase and topoisomerase IV. J Urol2000; 164: 847. Link, Google Scholar
• 22 : Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep2006; 55: 1. Google Scholar
• 23 : Emergence of cephem- and aztreonam-high-resistant Neisseria gonorrhoeae that does not produce beta-lactamase. J Infect Chemother2001; 7: 49. Google Scholar
• 24 : Outbreak of cefozopran (penicillin, oral cephems, and aztreonam)-resistant Neisseria gonorrhoeae in Japan. Antimicrob Agents Chemother2001; 45: 3603. Google Scholar
• 25 : A remarkable reduction in the susceptibility of Neisseria gonorrhoeae isolates to cephems and the selection of antibiotic regimens for the single-dose treatment of gonococcal infection in Japan. J Infect Chemother2002; 8: 81. Google Scholar
• 26 : Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime and ceftriaxone: association with genetic polymorphisms in penA, mtrR, porB1b, and ponA. Antimicrob Agents Chemother2007; 51: 2117. Google Scholar
• 27 : Mosaic-like structure of penicillin-binding protein 2 Gene (penA) in clinical isolates of Neisseria gonorrhoeae with reduced susceptibility to cefixime. Antimicrob Agents Chemother2002; 46: 3744. Google Scholar
• 28 : Emergence and spread of Neisseria gonorrhoeae clinical isolates harboring mosaic-like structure of penicillin-binding protein 2 in central Japan. Antimicrob Agents Chemother2005; 49: 137. Google Scholar
• 29 : Diversity of penA alterations and subtypes in Neisseria gonorrhoeae strains from Sydney, Australia, that are less susceptible to ceftriaxone. Antimicrob Agents Chemother2007; 51: 3111. Google Scholar
• 30 : Ceftibuten resistance and treatment failure of Neisseria gonorrhoeae infection. Antimicrob Agents Chemother2008; 52: 3564. Google Scholar
• 31 : Mosaic penicillin-binding protein 2 in Neisseria gonorrhoeae isolates collected in 2008 in San Francisco, California. Antimicrob Agents Chemother2009; 53: 4032. Google Scholar
• 32 : Decreased affinity of mosaic-structure recombinant penicillin-binding protein 2 for oral cephalosporins in Neisseria gonorrhoeae. J Antimicrob Chemother2007; 60: 54. Google Scholar
• 33 : Threat to cefixime treatment for gonorrhea. Emerg Infect Dis2007; 13: 1275. Google Scholar
• 34 : Rapid detection of the mosaic structure of the Neisseria gonorrhoeae penA gene, which is associated with decreased susceptibilities to oral cephalosporins. J Clin Microbiol2008; 46: 1804. Google Scholar
• 35 : Multidrug-resistant Neisseria gonorrhoeae with decreased susceptibility to cefixime-Hawaii, 2001. Clin Infect Dis2003; 37: 849. Google Scholar
• 36 : Single dose (direct observed) azithromycin therapy for Neisseria gonorrhoeae and Chlamydia trachomatis in STD clinic attenders with genital discharge in Trinidad and Tobago. West Indian Med J2001; 50: 198. Google Scholar
• 37 : Efficacy of azithromycin 1g single dose in the management of uncomplicated gonorrhoea. Int J STD AIDS2004; 15: 240. Google Scholar
• 38 : Failure of azithromycin therapy in gonorrhea and discorrelation with laboratory test parameters. Sex Transm Dis1998; 25: 505. Google Scholar
• 39 : Multicenter trial of single-dose azithromycin vs. ceftriaxone in the treatment of uncomplicated gonorrhea: Azithromycin Gonorrhea Study Group. Sex Transm Dis1994; 21: 107. Google Scholar
• 40 : Clinical pharmacokinetics and gastrointestinal tolerability of a novel extended-release microsphere formulation of azithromycin. Clin Pharmacokinet2007; 46: 247. Google Scholar
• 41 : Mutation in 23S rRNA associated with macrolide resistance in Neisseria gonorrhoeae. Antimicrob Agents Chemother2002; 46: 3020. Google Scholar
• 42 : Discontinuation of spectinomycin. MMWR Morb Mortal Wkly Rep2006; 55: 370. Google Scholar
• 43 : Further questions regarding the role of mosaic penA sequences in conferring reduced susceptibility to ceftriaxone in Neisseria gonorrhoeae. Antimicrob Agents Chemother2007; 51: 802. Google Scholar
• 44 : Role of interspecies transfer of chromosomal genes in the evolution of penicillin resistance in pathogenic and commensal Neisseria species. J Mol Evol1992; 34: 115. Google Scholar
• 45 : Single dose 1 g ceftriaxone for urogenital and pharyngeal infection caused by Neisseria gonorrhoeae. Int J Urol2008; 15: 837. Google Scholar
• 46 : Single dose of cefodizime completely eradicated multidrug-resistant strain of Neisseria gonorrhoeae in urethritis and uterine cervicitis. J Infect Chemother2006; 12: 97. Google Scholar
• 47 : Multiple doses of cefodizime are necessary for the treatment of Neisseria gonorrhoeae pharyngeal infection. J Infect Chemother2006; 12: 145. Google Scholar
• 48 : Antibiotic resistance in Neisseria gonorrhoeae is diminishing available treatment options for gonorrhea: some possible remedies. Expert Rev Anti Infect Ther2006; 4: 619. Google Scholar
• 49 : Lack of nationwide surveillance of antimicrobial resistance of Neisseria gonorrhoeae in Japan. Ann Intern Med2008; 149: 363. Google Scholar
• 50 : Decreased susceptibility of Neisseria gonorrhoeae to fluoroquinolones–Ohio and Hawaii, 1992–1994. MMWR Morb Mortal Wkly Rep1994; 43: 325. Google Scholar